nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Methyclothiazide—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00398	0.00398	CcSEcCtD
Methyclothiazide—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00398	0.00398	CcSEcCtD
Methyclothiazide—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Methyclothiazide—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Methyclothiazide—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00388	0.00388	CcSEcCtD
Methyclothiazide—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00388	0.00388	CcSEcCtD
Methyclothiazide—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.00384	0.00384	CcSEcCtD
Methyclothiazide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Methyclothiazide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00381	0.00381	CcSEcCtD
Methyclothiazide—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Methyclothiazide—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.00374	0.00374	CcSEcCtD
Methyclothiazide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Methyclothiazide—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Methyclothiazide—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Epirubicin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Methyclothiazide—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Methyclothiazide—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Methyclothiazide—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Epirubicin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Methyclothiazide—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Methyclothiazide—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Methyclothiazide—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Doxorubicin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Methyclothiazide—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Methyclothiazide—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Methyclothiazide—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Methyclothiazide—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Methyclothiazide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Methyclothiazide—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Methyclothiazide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Methyclothiazide—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Methyclothiazide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Methyclothiazide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Methyclothiazide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Methyclothiazide—Constipation—Topotecan—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Methyclothiazide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Methyclothiazide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Methyclothiazide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Methyclothiazide—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Methyclothiazide—Agitation—Vincristine—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Methyclothiazide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Methyclothiazide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Methyclothiazide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Methyclothiazide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Methyclothiazide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Methyclothiazide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Methyclothiazide—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Methyclothiazide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Methyclothiazide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Methyclothiazide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Methyclothiazide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Methyclothiazide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Methyclothiazide—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Methyclothiazide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Methyclothiazide—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Methyclothiazide—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Methyclothiazide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Methyclothiazide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Methyclothiazide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Methyclothiazide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Methyclothiazide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Methyclothiazide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Methyclothiazide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Methyclothiazide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Methyclothiazide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Methyclothiazide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Methyclothiazide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Methyclothiazide—Purpura—Epirubicin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Methyclothiazide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Methyclothiazide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Methyclothiazide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Methyclothiazide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Methyclothiazide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Methyclothiazide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Methyclothiazide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Methyclothiazide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Methyclothiazide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Methyclothiazide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Methyclothiazide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Methyclothiazide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Methyclothiazide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Methyclothiazide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Methyclothiazide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Methyclothiazide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Methyclothiazide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Methyclothiazide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Methyclothiazide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Methyclothiazide—Rash—Topotecan—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Methyclothiazide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Methyclothiazide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Methyclothiazide—Headache—Topotecan—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Methyclothiazide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Methyclothiazide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Methyclothiazide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Methyclothiazide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Methyclothiazide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Methyclothiazide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Methyclothiazide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Methyclothiazide—Constipation—Vincristine—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Methyclothiazide—Rash—Melphalan—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Methyclothiazide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Methyclothiazide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Methyclothiazide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Methyclothiazide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Methyclothiazide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Methyclothiazide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Methyclothiazide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Methyclothiazide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Methyclothiazide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Methyclothiazide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Methyclothiazide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Methyclothiazide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Methyclothiazide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Methyclothiazide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Methyclothiazide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Methyclothiazide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Methyclothiazide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Methyclothiazide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Methyclothiazide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Methyclothiazide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Methyclothiazide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Methyclothiazide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Methyclothiazide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Methyclothiazide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Methyclothiazide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Methyclothiazide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Methyclothiazide—Constipation—Etoposide—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Methyclothiazide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Methyclothiazide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Methyclothiazide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Methyclothiazide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Methyclothiazide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Methyclothiazide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Methyclothiazide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Methyclothiazide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Methyclothiazide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Methyclothiazide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Methyclothiazide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Methyclothiazide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Methyclothiazide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Methyclothiazide—Rash—Vincristine—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Methyclothiazide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Methyclothiazide—Headache—Vincristine—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Methyclothiazide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Methyclothiazide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Methyclothiazide—Nausea—Vincristine—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Methyclothiazide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Methyclothiazide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Methyclothiazide—Rash—Cisplatin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Methyclothiazide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Methyclothiazide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Methyclothiazide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Methyclothiazide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Methyclothiazide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Methyclothiazide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Methyclothiazide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Methyclothiazide—Rash—Etoposide—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Methyclothiazide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Methyclothiazide—Headache—Etoposide—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Methyclothiazide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Methyclothiazide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Methyclothiazide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Methyclothiazide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Methyclothiazide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000994	0.000994	CcSEcCtD
Methyclothiazide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00095	0.00095	CcSEcCtD
Methyclothiazide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00092	0.00092	CcSEcCtD
Methyclothiazide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000908	0.000908	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000905	0.000905	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000904	0.000904	CcSEcCtD
Methyclothiazide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000842	0.000842	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00084	0.00084	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000836	0.000836	CcSEcCtD
Methyclothiazide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00082	0.00082	CcSEcCtD
Methyclothiazide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000782	0.000782	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000779	0.000779	CcSEcCtD
Methyclothiazide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000759	0.000759	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000756	0.000756	CcSEcCtD
Methyclothiazide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000727	0.000727	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.000724	CcSEcCtD
Methyclothiazide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Methyclothiazide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00072	0.00072	CcSEcCtD
Methyclothiazide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000716	0.000716	CcSEcCtD
Methyclothiazide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000699	0.000699	CcSEcCtD
Methyclothiazide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000673	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000666	0.000666	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Methyclothiazide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000628	CcSEcCtD
